Innovator’s Pitch Challenge

Interested in Connecting? Please contact:
Dr. Viraj Mane
Chief Scientific Officer; Co-founder

Message the company or request a 1:1 meeting here

Lactiga, an award-winning biotherapeutics company developing anti-infective biologics, is creating novel therapeutics targeting immunodeficiencies. Its lead product, LCTG-001, is designed for patients with Primary Immunodeficiency Diseases (PID), including Selective IgA Deficiency (SIgAD) and Common Variable Immunodeficiency (CVID).

Pitch Video

Slide Deck